Outcomes and Toxicity in Patients Treated With Intensity Modulated Radiation Therapy (IMRT) for Esophageal Carcinoma
Ajay Patel(Jacksonville College), Stephen Ko(Mayo Clinic in Florida), William G. Rule(Mayo Clinic in Arizona), Christopher L. Hallemeier(Mayo Clinic in Arizona), Robert C. Miller(Mayo Clinic), Sarah E. James(Mayo Clinic), C. Hobbs(Mayo Clinic in Florida), J.B. Ashman(Mayo Clinic Hospital), Emily Vargas(Jacksonville College), Michael G. Heckman(Mayo Clinic in Florida)
International Journal of Radiation Oncology*Biology*Physics
October 1, 2016
Cited by 0
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
|The Lancet Neurology|2011|344
Testicular Cancer Survivorship: Research Strategies and Recommendations
|JNCI Journal of the National Cancer Institute|2010|289